Global Antimicrobial Resistance and Use Surveillance System on the African continent: Early implementation 2017-2019

• Main Authors: Barbara Tornimbene (Author), Sergey Eremin (Author), Reuben Abednego (Author), Elamin O. Abualas (Author), Ilhem Boutiba (Author), Abiodun Egwuenu (Author), Walter Fuller (Author), Laetitia Gahimbare (Author), Susan Githii (Author), Watipaso Kasambara (Author), Chileshe Lukwesa-Musyani (Author), Fidy A. Miamina (Author), Sekesai Mtapuri-Zinyowera (Author), Grace Najjuka (Author), Olga Perovic (Author), Bassem Zayed (Author), Yahaya A. Ahmed (Author), Maha T. Ismail (Author), Carmem L. Pessoa da Silva (Author)
• Format: Book
• Published: AOSIS, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2225-2002; 2225-2010; 10.4102/ajlm.v11i1.1594
• Keywords: amr; surveillance; africa; implementation; who; Public aspects of medicine; RA1-1270; Medicine (General); R5-920
• Source: African Journal of Laboratory Medicine, Vol 11, Iss 1, Pp e1-e11 (2022)

Background: Antimicrobial resistance (AMR) is becoming a critical public health issue globally. The World Health Organization launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) to support the strengthening of the AMR evidence base. Objective: The article describes the evolution of national AMR surveillance systems and AMR data reporting of countries in the African continent between 2017 and 2019, and the constraints, perceived impact and value of the participation in GLASS. Methods: Data on implementation of national surveillance systems and AMR rates were submitted to GLASS between 2017 and 2019 and summarised though descriptive statistics. The information on constraints and perceived impact and value in GLASS participation was collected though a set of questionnaires. Results: Between 2017 and 2019, Egypt, Ethiopia, Madagascar, Malawi, Mali, Mozambique, Nigeria, South Africa, Sudan, Tunisia, Uganda and Zambia submitted data to GLASS. The main constraints listed are linked to scarce laboratory capacity and capability, limited staffing, budget issues, and data management. Moreover, while the data are not yet nationally representative, high resistance rates were reported to commonly-used antibiotics, as the emerging resistance to last treatment options. Conclusion: Despite the limitations, more and more countries in the African continent are working towards reaching a status that will enable them to report AMR data in a complete and systematic manner. Future improvements involve the expansion of routine surveillance capacity for several countries and the implementation of surveys that allow to effectively define the magnitude of AMR in the continent.